Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy in Serosa-positive Gastric Cancer
NCT00147147Phase 3Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- Jan 1993
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin, fluorouracil and tegafur + uracil in gastric cancer (GC) (2 arms), sponsored by Japan Clinical Oncology Group. Primary endpoint: Overall Survival. Started Jan 1993; status: completed.
02
Drugs
cisplatinfluorouraciltegafur + uracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00147147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147147.